AccuGel 29:1 is a stabilized, ready-to-use solution of 40% (w/v) acrylamide : bisacrylamide(29:1). AccuGel 29:1 has zero acrylic acid content, eliminating the fixed charges that cause band streaking. Additionally, oxidation products such as aldehydes have been removed by a selective adsorption process. With AccuGel 29:1, you can trust that your results will be consistent from one electrophoretic run to the next.
Improved Safety
AccuGel 29:1 reduces exposure to neurotoxic acrylamide dust by eliminating the need for handling and weighing solid acrylamide and methylene bisacrylamide, which often leads to airborne particulate that can be readily inhaled. For your protection, AccuGel 29:1 is supplied in PVC coated shatter-proof bottles.
Stable and Pure
AccuGel 29:1 is stable for 24 months when stored tightly capped in a dark area at room temperature. Potential Health EffectsInhalation
Inhalation of mist causes irritation to the respiratory tract. Symptoms may parallel ingestion. Ingestion
Toxic! May cause systemic poisoning. May cause drowsiness, tingling sensations, fatigue, weakness, stumbling, slurred speech, and shaking. May cause central and peripheral nervous system damage. Severe intoxication may cause permanent nerve damage. May affect reproductive system and act as a teratogen.
AccuGel
Skin
May cause irritation and redness. Can be absorbed through the skin causing systemic poisoning; symptoms may parallel ingestion. Eyes
Acrylamide solutions may cause eye irritation. Carcinogenicity
Acrylamide is suspected as a cancer hazard. May cause cancer. Listed by NTP as a suspected carcinogen. Acrylamide is known to the State of California to cause cancer. Mutagenicity
Acrylamide was negative in the Ames assay both with and without metabolic activation. Reproductive Toxicity
Acrylamide induced male reproductive toxicity has been demonstrated in Long-Evans rats where given greater than or equal to 15 mg/kg/day acrylamide orally by gavage for five consecutive days. In this study, males receiving greater than or equal to 15 mg/kg/day acrylamide had a reduced fertility index.
